n.核固缩

Karyopyknosis is a characteristic feature of senescent cells, where chromatin condenses and the nuclear size decreases.
衰老细胞的一个特征是核染色质凝聚，核体积减小。
In cancer cells undergoing apoptosis, karyopyknosis is often observed as the first stage of nuclear fragmentation.
在进行凋亡的癌细胞中，通常会观察到核染色质凝聚，这是核碎裂的第一阶段。
Karyopyknosis can be detected through microscopic examination of stained cell nuclei, aiding in diagnosis of certain diseases.
通过染色细胞核的显微镜检查可以检测到核染色质凝聚，有助于某些疾病的诊断。
The progression of Alzheimer's disease has been linked to increased karyopyknosis in neurons, affecting their function.
阿尔茨海默病的发展与神经元中核染色质凝聚增加有关，影响其功能。
Researchers studying cellular aging found that karyopyknosis was more prevalent in older organisms compared to younger ones.
研究细胞衰老的研究人员发现，核染色质凝聚在年长生物体中比年轻生物体更常见。
Treatment targeting karyopyknosis may hold promise for reversing age-related cellular decline in some organisms.
针对核染色质凝聚的治疗可能对逆转某些生物体的年龄相关细胞衰退有前景。
In response to environmental stress, cells may undergo karyopyknosis as a protective mechanism to prevent further damage.
在应对环境压力时，细胞可能会经历核染色质凝聚作为保护机制，防止进一步损伤。
Scientists have observed karyopyknosis in stem cells during the differentiation process, marking a transition to a specialized cell type.
科学家在干细胞分化过程中观察到核染色质凝聚，标志着向特定细胞类型的转变。
Karyopyknosis is a key indicator of cellular senescence, which can be triggered by factors like radiation or chemotherapy.
核染色质凝聚是细胞衰老的关键标志，这可能是由辐射或化疗等因素触发的。
Understanding the role of karyopyknosis in various cellular processes could lead to new therapeutic strategies for treating age-related diseases.
理解核染色质凝聚在各种细胞过程中的作用可能为治疗与年龄相关的疾病开辟新途径。